Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-25 @ 10:25 PM
NCT ID: NCT00063258
Description: None
Frequency Threshold: 0
Time Frame: Adverse events were collected from study activation (June 17, 2003) to 30 days following last dose of study treatment (approximately 2 years and 5 months)
Study: NCT00063258
Study Brief: Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Chemotherapy + Tarceva None None None 1 5 1 5 View
Chemotherapy Alone None None None 0 0 0 0 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hemoptysis (Grade 1) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders NCI CTC Version 2.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal Cramping (Grade 2) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTC Version 2.0 View
Alopecia (Grade 2) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders NCI CTC Version 2.0 View
Bilirubin Increase (Grade 1) SYSTEMATIC_ASSESSMENT Hepatobiliary disorders NCI CTC Version 2.0 View
Diarrhea (Grade 3) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTC Version 2.0 View
Dry Skin (Grade 2) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders NCI CTC Version 2.0 View
Dysphagia (Grade 1) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTC Version 2.0 View
Fatigue (Grade 2) SYSTEMATIC_ASSESSMENT General disorders NCI CTC Version 2.0 View
Infection Clinical with Grade 3-4 ANC (Wound) SYSTEMATIC_ASSESSMENT Infections and infestations NCI CTC Version 2.0 View
Nausea (Grade 1) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTC Version 2.0 View
Nausea (Grade 3) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTC Version 2.0 View
Neuropathy: Sensory (Grade 1) SYSTEMATIC_ASSESSMENT Nervous system disorders NCI CTC Version 2.0 View
Pain (Grade 2) SYSTEMATIC_ASSESSMENT General disorders NCI CTC Version 2.0 View
Palpitations (Grade 3) SYSTEMATIC_ASSESSMENT Cardiac disorders NCI CTC Version 2.0 View
Rash/Desquamation (Grade 3) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders NCI CTC Version 2.0 View
Stomatitis (Grade 2) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTC Version 2.0 View
Taste Alteration (Grade 2) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTC Version 2.0 View
Vomiting (Grade 2) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders NCI CTC Version 2.0 View
Infection with Normal ANC (Bladder -Urinary) Grade 2 SYSTEMATIC_ASSESSMENT Infections and infestations NCI CTC Version 2.0 View
Infection with Normal ANC (Wound) Grade 2 SYSTEMATIC_ASSESSMENT Infections and infestations NCI CTC Version 2.0 View
Myalgia (Grade 3) SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders NCI CTC Version 2.0 View